CENTRIMAG 1ST GENERATION PRIMARY CONSOLE 102954

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a other report with the FDA on 2020-01-10 for CENTRIMAG 1ST GENERATION PRIMARY CONSOLE 102954 manufactured by Thoratec Switzerland Gmbh.

Event Text Entries

[176011415] The centrimag motor was captured under mfr# 2916596-2019-03827. The centrimag blood pump was captured under mfr# 2916596-2019-03835. No further information was provided. A supplemental report will be submitted when the manufacturer? S investigation is completed.
Patient Sequence No: 1, Text Type: N, H10


[176011416] The patient was implanted with an extracorporeal circulatory support pump on (b)(6) 2019. It was reported that the patient was in cardiogenic shock and was initiated on dual centrimag acute support with an oxygenator attached to the right-sided support. Going into the intensive care unit (icu), the left ventricular assist device (lvad) was set at 4000 with 4. 7lpm flow and the right vad was set at 2700 with 4lpm flow. Approximately an hour after getting into the icu from the operating room, the cardiologist received an s3 alarm with a loud noise coming from the motor and pump on the lvad and that the motor was hot to the touch. Healthcare professionals immediately switched to the backup motor and there have been no alarms since. The patient was in critical health status due to being in shock and not due to the event. It was also reported that there was additional incident on (b)(6) 2019 in the evening following the switch to full backup system due to rattling sound from pump and s3 alarm. No further alarms have occurred since the switch to full backup system. Photos were provided of the pump secured in the motor on the new system to ensure secure pump placement. On (b)(6) 2019, the patient experienced significant flow fluctuations and apparent suck down at drainage cannula. Volume was given to the patient but flow fluctuations persisted. The patient was taken to the catheterization lab where a "huge left ventricle thrombus" was identified. This was thought to be the cause of the drop in flow and flow fluctuations and the patient was otherwise doing fine. Treatment for the thrombus was to explant the centrimag and implant with a heartmate 3 lvad on (b)(6) 2019. The centrimag console was added as a result of the investigation that concluded other causes may have contributed to the reported events besides thrombus.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2916596-2020-00153
MDR Report Key9576361
Report SourceOTHER
Date Received2020-01-10
Date of Report2020-01-27
Date of Event2019-08-02
Date Mfgr Received2020-01-24
Date Added to Maude2020-01-10
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. BOB FRYC
Manufacturer Street6035 STONERIDGE DRIVE
Manufacturer CityPLEASANTON CA 94588
Manufacturer CountryUS
Manufacturer Postal94588
Manufacturer Phone7818528204
Manufacturer G1THORATEC SWITZERLAND GMBH
Manufacturer StreetTECHNOPARKSTRASSE 1
Manufacturer CityZURICH CH-8005
Manufacturer CountrySZ
Manufacturer Postal CodeCH-8005
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCENTRIMAG 1ST GENERATION PRIMARY CONSOLE
Generic NameCONTROL, PUMP SPEED, CARDIOPULMONARY BYPASS
Product CodeDWA
Date Received2020-01-10
Model Number102954
Catalog Number102954
OperatorLAY USER/PATIENT
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerTHORATEC SWITZERLAND GMBH
Manufacturer AddressTECHNOPARKSTRASSE 1 ZURICH CH-8005 SZ CH-8005


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization; 2. Required No Informationntervention 2020-01-10

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.